In this piece, we will look at the stocks Jim Cramer discussed. 

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed the use cases surrounding AI and his expectations related to the technology’s future. The conversation started when co-host Carl Quintanilla asked Cramer about his recent tweets, which appeared to discuss AI spending and data center construction:

“Well I think that I, I have Johnson & Johnson today. And you could argue that they are the foremost pharmaceutical company. And yet when I go through their portfolio, they’re not talking about AI to invent medicine. They’re not talking about AI to cure cancer. AI, as it currently is, is not going to give you the return. The future I think that it can. But I think that our brains are a little, are constraining us. I think we can’t think about how it’s going to work. That’s why I rely on Jensen Huang, CEO of NVIDIA so much, because at least he has a vision about how it can be used. Right now I think it’s kind of super Google. It’s got to be more than that super Google.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on the Street aired on September 26th.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

5. Apple Inc. (NASDAQ:AAPL)

Number of Hedge Fund Holders In Q2 2025: 156

Since the iPhone 17 launch, Cramer has discussed Apple Inc. (NASDAQ:AAPL) regularly on his morning show. He continues to assert that consumer interest in the iPhone 17 launch is quite strong. More recently, he also commented on media reports suggesting that Intel had asked Apple Inc. (NASDAQ:AAPL) for an investment. In a Mad Money episode, Cramer even pointed out that while the firm could build Intel’s foundries, it wasn’t “Apple’s area of expertise.” This time, he discussed Apple Inc. (NASDAQ:AAPL)’s product reception and the shares’ overall relation to mega-cap stocks:

“Well, David, Carl, this Apple decline, I don’t know. After what I saw last night in Japan, I think that you can take a breather if you don’t want to buy, it was up yesterday. But this 17 is a worldwide sensation and we have to start noting the fact that Apple is the winner right now of what I regard the mega caps. And that’s because it hasn’t spent a fortune but it may get they get to be a beneficiary of everybody else spending a fortune. So let’s keep that in mind as people sell it and take profits.”

4. Alphabet Inc. (NASDAQ:GOOGL)

Number of Hedge Fund Holders In Q2 2025: 219

If there’s one thing that can be said for sure, it’s that Jim Cramer has changed his mind about Alphabet Inc. (NASDAQ:GOOGL) this year. Earlier in the year, the CNBC TV host was worried about the firm’s tussles with the Justice Department. However, since then, he has praised Alphabet Inc. (NASDAQ:GOOGL)’s YouTube business, its dominance in the search engine space, and Google Cloud. Cramer also believes that the firm is one of the top players in the quantum computing industry. This time, Cramer commented on YouTube TV as he and co-host David Faber discussed the medium’s rise in broadcasting:

“Look Alphabet is a company, that when they got out from under the Justice Department, they completely blossomed, And YouTube TV, I’m glad you mentioned it, because if you go to YouTube, that’s not YouTube TV. Is a remarkable product. Although I would tell you, when I was watching that Baltimore-Detroit game, I was hoping there might be a field goal for fantasy. It turned out the game was over! It was a delay. I couldn’t believe it!”

3. Costco Wholesale Corporation (NASDAQ:COST)

Number of Hedge Fund Holders In Q2 2025: 91

Costco Wholesale Corporation (NASDAQ:COST) continues to be one of Cramer’s top stocks. Throughout the year, he has praised the firm’s intent to secure low prices for consumers. This time, he discussed Costco Wholesale Corporation (NASDAQ:COST)’s fiscal fourth quarter earnings, which saw the firm’s $86.16 billion in revenue and $5.87 in EPS beat analyst estimates of $86.06 billion and $5.80. The earnings were followed by a share price dip, and here is what Cramer said:

“Okay so this is a stock that we’ve owned for the Charitable Trust for I don’t know, since we started. And, I have become schooled in this company to know that anytime it goes below 50 times earnings, that’s when you buy it. I’ve been telling the club members, look, go down, the actual numbers were fine. Some people thought it was better than expected. There’s just a little bit delta which is that they didn’t have the signups that we would like. This stock has a history of literally going huge up and then resting and then having a decline and then being ready to go again. As it goes below that key multiple level. Charlie Munger always said, Costco’s always expensive but it’s the best. And the late Munger was a fantastic investor. Here we are. Below 50 times earnings. It’s time. It’s time to buy. Now David, the chart’s horrible, okay, and I know that that’s something periodically you’re focused on. But it can go below 900. I mean certainly that’s within the realm. But everything is great at Costco. And I do my checks at Costco. And I gotta tell you, this was just a remarkable quarter, but people wanted more. And I think they also were very candid. That they said, listen the tariffs are hurting us. We’re doing our best to keep the costs down. So therefore people feel like going forward the margins could be hurt. I have tremendous faith in this team. This is one again, this is one of the longest term, greatest owning stocks ever. And I’m not backing away. But I did say yesterday, don’t buy it ahead cause it’s still above 50 times earnings, well here we are. I told people to buy Boeing instead. . .It was 52 times earnings yesterday.

“But it’s always been rich. You have to accept that. You come to the nuisance of that being rich. Let it come down. You can get it at 49, 48 times earnings. That is about as cheap as it’s going to get. David, it’s not Palantir, it’s no Palantir, but I do think that their business model is great, they save you a lot of money, the card’s terrific. And I think that the management team is every bit as good as bit’s always been. Do I miss Richard Galanti who was the CFO for so many, 38 years, of course I do, everybody does, but I am very confident that this is business as usual at Costco and if you read the conference call you will know exactly that.”

2. The Boeing Company (NYSE:BA)

Number of Hedge Fund Holders In Q2 2025: 101

The Boeing Company (NYSE:BA) experienced some good news last week when the Federal Aviation Administration (FAA) announced that it had allowed the firm to sign off on some of its Boeing 737 Max and 787 Dreamliner aircraft before handing them over to customers. The development came after the regulator had stopped The Boeing Company (NYSE:BA) in 2019 from issuing airworthiness certificates. Cramer discussed the development:

“The trust has been buying Boeing hand over fist over the last two weeks. Because it’s just so obvious that they were gonna get these big orders from the President. I was not optimistic that you’d get this FAA, until maybe at least, maybe at the end of the year. So this is a very big deal for Kelly Ortberg. He had been very conservative. He did not tell you that this was in the bag. Go back to his last talk. He basically just said, look, we’re not where we want to be at. And a lot of people sold the stock. And it went from 225 to 215, straight line. Great opportunity to buy. And the trust has been buying it hand over fist.”

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders In Q2 2025: 95

Johnson & Johnson (NYSE:JNJ) is one of the most diversified healthcare companies in the world. The firm operates in the pharmaceutical, medical devices, and other industries. Cramer previously discussed the stock on September 11th, when he wondered whether the major “litigation overhang” surrounding the firm actually involved an “overplayed” hand by the plaintiffs’ lawyers. This time, he was full of praise for Johnson & Johnson (NYSE:JNJ)’s cancer portfolio:

“Well tonight we got JNJ and it’s incredibly important because Joaquin, he does not, he does not do a lot of, he does no interviews, frankly. And I think this is a terrific time because we also have. Look, they’re spending more than 50 billion. I think that they are really at the forefront of building in America. Other than Eli Lilly. So I want to ask about that. Other than that, the stuff that they’re doing against cancer. It’s so incredible. I think we gotta talk about that. I think they are now ahead of everyone, in terms of trying to cure cancer. And I don’t use that word lightly because my ma died of cancer in a horrible fashion, and it’s a cancer that’s been cured since then.”

While we acknowledge the potential of JNJ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than JNJ and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.